Circulation Acceptance Rate

The desk: clinical vs. basic science

The fastest desk rejections happen when a paper is fundamentally basic cardiovascular science. A study of cardiac ion channel regulation at the molecular level, without any clinical bridge, belongs at Circulation Research (IF 16.5), not Circulation. The editors make this distinction quickly.

Papers that survive the desk typically answer "yes" to: would a practicing cardiologist read this and consider changing something about how they treat patients?

That doesn't mean the paper has to be a clinical trial. Translational work counts. But the translational bridge needs to be visible, not theoretical.

Peer review: evidence strength

Among papers that enter review, rejection usually comes from:

• The clinical endpoints aren't strong enough (surrogate markers instead of hard outcomes)
• The study design has limitations that undermine the clinical conclusion
• The population is too narrow for Circulation's broad cardiovascular readership
• The finding replicates what's already known without adding a meaningful new dimension

The AHA family redirect

Circulation sits atop the AHA journal family. When editors see merit but not flagship-level importance, they often offer to transfer to Circulation: Heart Failure, Circulation: Arrhythmia, or another specialty title. These are respected journals in their own right (IFs 9-25), and the transfer typically comes with the editor's recommendation.

Taking the transfer seriously is often the right move. A paper that's borderline for Circulation may be a strong acceptance at a specialty title.

Submit if:

• the finding changes how cardiologists understand or treat cardiovascular disease
• the evidence is clinical or has a clear translational bridge to patient care
• the study population and endpoints are broad enough for the AHA's flagship readership
• you're comfortable with the AHA family cascade if the paper doesn't clear the flagship

Think twice if:

• the paper is primarily basic cardiovascular biology (Circulation Research is the better target)
• the finding is specific to one cardiovascular subspecialty (a Circulation specialty title may fit better)
• European Heart Journal or JACC would reach your target audience more effectively
• the clinical implications are speculative rather than evidence-supported

A free manuscript scan can help assess whether the cardiovascular framing meets Circulation's clinical threshold before you submit.

What is the Circulation acceptance rate?

Approximately 10-12%. Most rejections happen at the desk (70%+).

How hard is it to publish in Circulation?

Selective but not impossible. The key filter is clinical relevance. Basic cardiovascular science belongs at Circulation Research. Clinical and translational work with clear patient-care implications has the best chance.

Does Circulation transfer papers to specialty journals?

Yes. The AHA journal family includes Circulation: Heart Failure, Circulation: Arrhythmia and Electrophysiology, and others. Editors often offer transfers for papers with cardiovascular merit below the flagship threshold.

What's the difference between Circulation and JACC?

Circulation is AHA-affiliated. JACC is ACC-affiliated. The scope overlaps substantially. Circulation emphasizes cardiovascular science broadly; JACC emphasizes clinical cardiology practice.